(S)-N-(4-(benzyloxy)benzyl)pyrrolidine-2-carboxamide

ID: ALA1091104

PubChem CID: 46884101

Max Phase: Preclinical

Molecular Formula: C19H22N2O2

Molecular Weight: 310.40

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(NCc1ccc(OCc2ccccc2)cc1)[C@@H]1CCCN1

Standard InChI:  InChI=1S/C19H22N2O2/c22-19(18-7-4-12-20-18)21-13-15-8-10-17(11-9-15)23-14-16-5-2-1-3-6-16/h1-3,5-6,8-11,18,20H,4,7,12-14H2,(H,21,22)/t18-/m0/s1

Standard InChI Key:  RRCBFAKQOPNBBC-SFHVURJKSA-N

Molfile:  

     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -1.9972  -14.2030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9983  -15.0304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2835  -15.4432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5672  -15.0299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5700  -14.1994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2853  -13.7904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1480  -15.4412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8617  -15.0277    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5768  -15.4390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2905  -15.0254    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5781  -16.2640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9160  -16.7501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1722  -17.5343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9972  -17.5330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2507  -16.7480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7116  -13.7908    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4259  -14.2034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1405  -13.7911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1370  -12.9655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8506  -12.5534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5660  -12.9660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5631  -13.7953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8488  -14.2037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11 12  1  0
  5  6  2  0
  6  1  1  0
  1  2  2  0
  4  7  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
  3  4  2  0
  1 16  1  0
  7  8  1  0
 16 17  1  0
 17 18  1  0
  8  9  1  0
 18 19  2  0
  4  5  1  0
 19 20  1  0
  9 10  2  0
 20 21  2  0
  2  3  1  0
 21 22  1  0
 11  9  1  6
 22 23  2  0
 23 18  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA1091104

   (S)-N-(4-(benzyloxy)benzyl)pyrrolidine-2-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 310.40

Molecular Weight (Monoisotopic): 310.1681

AlogP: 2.63

#Rotatable Bonds: 6

Polar Surface Area: 50.36

Molecular Species: BASE

HBA: 3

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 9.81

CX LogP: 2.61

CX LogD: 0.26

Aromatic Rings: 2

Heavy Atoms: 23

QED Weighted: 0.86

Np Likeness Score: -0.74

References

1. Liu KK, Lefker BA, Dombroski MA, Chiang P, Cornelius P, Patterson TA, Zeng Y, Santucci S, Tomlinson E, Gibbons CP, Marala R, Brown JA, Kong JX, Lee E, Werner W, Wenzel Z, Giragossian C, Chen H, Coffey SB..  (2010)  Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity.,  20  (7): [PMID:20202843] [10.1016/j.bmcl.2010.01.107]

Source

Source(1):

• Scientific Literature